Paul L Proffer, MD | |
1611 Wallace Blvd, Amarillo, TX 79106-1799 | |
(806) 354-4900 | |
(806) 352-4987 |
Full Name | Paul L Proffer |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 29 Years |
Location | 1611 Wallace Blvd, Amarillo, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962488676 | NPI | - | NPPES |
105845503 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | K3932 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Proffer Surgical Associates, Llp | 3678579232 | 4 |
News Archive
A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form. The research was published ahead of print in Antimicrobial Agents and Chemotherapy.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
Researchers have found a more than twofold increase in the risk of death among patients with Parkinson's disease who take antipsychotics, particularly typical antipsychotics.
Liquid biopsies detect tumor DNA in blood or urine samples. Two studies led by Washington University School of Medicine in St. Louis describe the potential of liquid biopsies to identify and track tumor growth in two very different cancers: bladder cancer and peripheral nerve tumors.
Home-testing kits have made it easier for diabetics and hypertension patients to track their conditions, but such self-monitoring hasn't been possible for people with phenylketonuria (PKU).
› Verified 7 days ago
Entity Name | Proffer Surgical Associates, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164441333 PECOS PAC ID: 3678579232 Enrollment ID: O20061005000041 |
News Archive
A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form. The research was published ahead of print in Antimicrobial Agents and Chemotherapy.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
Researchers have found a more than twofold increase in the risk of death among patients with Parkinson's disease who take antipsychotics, particularly typical antipsychotics.
Liquid biopsies detect tumor DNA in blood or urine samples. Two studies led by Washington University School of Medicine in St. Louis describe the potential of liquid biopsies to identify and track tumor growth in two very different cancers: bladder cancer and peripheral nerve tumors.
Home-testing kits have made it easier for diabetics and hypertension patients to track their conditions, but such self-monitoring hasn't been possible for people with phenylketonuria (PKU).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Paul L Proffer, MD 1611 Wallace Blvd, Amarillo, TX 79106-1799 Ph: (806) 354-4900 | Paul L Proffer, MD 1611 Wallace Blvd, Amarillo, TX 79106-1799 Ph: (806) 354-4900 |
News Archive
A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form. The research was published ahead of print in Antimicrobial Agents and Chemotherapy.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
Researchers have found a more than twofold increase in the risk of death among patients with Parkinson's disease who take antipsychotics, particularly typical antipsychotics.
Liquid biopsies detect tumor DNA in blood or urine samples. Two studies led by Washington University School of Medicine in St. Louis describe the potential of liquid biopsies to identify and track tumor growth in two very different cancers: bladder cancer and peripheral nerve tumors.
Home-testing kits have made it easier for diabetics and hypertension patients to track their conditions, but such self-monitoring hasn't been possible for people with phenylketonuria (PKU).
› Verified 7 days ago
Robert E Gerald, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7625 Fleming Ave, Amarillo, TX 79106 Phone: 806-353-0125 Fax: 806-355-0834 | |
Amber A Dobler-dixon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-350-1100 Fax: 806-350-1101 | |
Bruce L Weinberger, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 700 Quail Creek Dr, Amarillo, TX 79124 Phone: 806-353-6691 Fax: 806-355-1284 | |
Christopher Alan Mccarty, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-351-1177 Fax: 806-355-1284 | |
Jason Edward Ysasaga, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-351-1870 Fax: 806-355-1284 | |
Dr. Sloan Whitmore Rush, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7625 Fleming Ave, Amarillo, TX 79106 Phone: 806-353-0125 Fax: 806-355-0834 | |
Jennifer Rene Gallagher, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-351-1870 |